Loading…
ProKidney Corp. is projected to rise to $1.84 by 2027, a +6% move from its current price of $1.74. PROK is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $1.68 | $1.74 | $1.80 | +0.01% |
| Jul 13 | $1.65 | $1.74 | $1.83 | +0.01% |
| Jul 14 | $1.64 | $1.74 | $1.85 | +0.02% |
| Jul 15 | $1.62 | $1.74 | $1.87 | +0.03% |
| Jul 16 | $1.61 | $1.74 | $1.89 | +0.04% |
| Jul 17 | $1.59 | $1.74 | $1.90 | +0.04% |
| Jul 18 | $1.58 | $1.74 | $1.91 | +0.05% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.58 | $1.74 | $1.91 | +0.05% |
| Week 2 | $1.52 | $1.74 | $1.99 | +0.10% |
| Week 3 | $1.48 | $1.74 | $2.05 | +0.15% |
| Week 4 | $1.44 | $1.74 | $2.11 | +0.20% |
| Week 5 | $1.41 | $1.74 | $2.16 | +0.25% |
| Week 6 | $1.38 | $1.75 | $2.20 | +0.30% |
| Week 7 | $1.36 | $1.75 | $2.24 | +0.35% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
ProKidney Corp. is a clinical-stage biotechnology company focused on developing cell therapies for chronic kidney diseases in the United States. It develops rilparencel, a cell therapy with autologous selected renal cells, which is in Phase III clinical trial for the treatment of advanced chronic kidney disease and type 2 diabetes.
It is also involved in the development of cryopreserved versions of rilparencel, including REGEN-006 and REGEN-008, which are both in Phase III clinical trials; REGEN-002, REGEN-003, and REGEN-007 which are in Phase II clinical trials; and REGEN-004 which is Phase I clinical trial. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
ProKidney Corp. (PROK) is currently trading at $1.84, with a market capitalization of $555.79M and a current ranking of 2967.
A major floor 18.8% below — a decisive break under it would weaken the trend.
The nearest floor, 5.7% below — buyers have tended to step in here.
The nearest ceiling, 17.2% above — a clean break opens room to run.
A major ceiling 42.5% above — clearing it would confirm fresh momentum.
Key PROK support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PROK market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.87 | Sell | $1.84 | Sell |
| MA 10 | $1.90 | Sell | $1.86 | Sell |
| MA 20 | $1.82 | Sell | $1.84 | Sell |
| MA 50 | $1.80 | Sell | $1.84 | Sell |
| MA 100 | $1.92 | Sell | $1.92 | Sell |
| MA 200 | $2.20 | Sell | $2.01 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.91 | Neutral |
| Stoch RSI (14) | 4.80 | Buy |
| CCI (20) | -41.00 | Neutral |
| Williams %R (14) | -82.35 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -2.22 | Sell |
| Bollinger %B (20,2) | 0.38 | Neutral |
| Stochastic %K (14) | 17.65 | Buy |
| TRIX (15) | 0.24 | Buy |
| Awesome (5,34) | 0.07 | Buy |
| Ultimate (7,14,28) | 34.46 | Neutral |
| Momentum (10) | 0.06 | Buy |
| Aroon Osc (25) | 44.00 | Buy |
| Hull MA (9) | 1.79 | Sell |
| ADX (14) | 11.29 | Neutral |
| ATR (14) | 0.07 | Info |
The near-term technical picture shows a bullish tilt in sentiment overall. The RSI14 is 50, and the stock trades around the 50-day simple moving average of $1.80 while the 200-day simple moving average stands at $2.21. Key near-term support sits at $1.64 and resistance at $2.04. Over the last 30 days the price has traded in a range from $1.43 to $2.36.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.55 | $1.74 | $2.30 | 0% | Neutral | |
| $1.43 | $1.84 | $2.55 | +6% | Neutral | |
| $1.48 | $1.99 | $2.89 | +15% | Neutral | |
| $1.28 | $1.77 | $2.66 | +2% | Neutral | |
| $1.24 | $1.78 | $2.75 | +2% | Neutral | |
| $1.38 | $2.02 | $3.21 | +16% | Neutral | |
| $1.58 | $2.37 | $3.85 | +36% | Bullish | |
| $1.73 | $2.66 | $4.41 | +53% | Bullish | |
| $1.65 | $2.59 | $4.39 | +49% | Bullish | |
| $1.60 | $2.56 | $4.42 | +47% | Bullish | |
| $2.17 | $3.83 | $7.11 | +120% | Bullish | |
| $2.44 | $5.14 | $10.61 | +195% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.55 | $1.74 | $2.16 | +0.00% |
| August 2026 | $1.52 | $1.81 | $2.22 | +4.00% |
| September 2026 | $1.46 | $1.75 | $2.18 | -3.23% |
| October 2026 | $1.46 | $1.77 | $2.23 | +0.85% |
| November 2026 | $1.49 | $1.82 | $2.31 | +2.79% |
| December 2026 | $1.45 | $1.78 | $2.30 | -1.68% |
Click any year to see its month-by-month PROK forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, PROK is projected to trade between $1.55 and $2.30, averaging $1.74 — a potential gain of 0% from today's $1.74. A consolidation phase looks the most probable path here.
ProKidney Corp.'s 2027 outlook centres on $1.84, within a $1.43 to $2.55 range. That is up +6% on the projected 2026 average. That marks a +6% change versus current levels. Price action looks broadly range-bound.
By 2028, PROK could reach as high as $2.89, with a base case around $1.99 and support toward $1.48 — roughly +15% from $1.74. A consolidation phase looks the most probable path here.
Expect PROK to range from $1.28 to $2.66 through 2029. The $1.77 average target implies a +2% move from current prices. That is -11% versus the projected 2028 average. Price action looks broadly range-bound.
The PROK price prediction for 2030 points to an average of $1.78 (low $1.24, high $2.75) — a potential gain of +2% on today's $1.74. A consolidation phase looks the most probable path here.
In 2031, PROK is projected to trade between $1.38 and $3.21, averaging $2.02 — a potential gain of +16% from today's $1.74. That is up +14% on the projected 2030 average. Price action looks broadly range-bound.
ProKidney Corp.'s 2032 outlook centres on $2.37, within a $1.58 to $3.85 range. That is up +17% on the projected 2031 average. That marks a +36% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, PROK could reach as high as $4.41, with a base case around $2.66 and support toward $1.73 — roughly +53% from $1.74. Momentum favours further upside here.
Expect PROK to range from $1.65 to $4.39 through 2034. The $2.59 average target implies a +49% move from current prices. That is -3% versus the projected 2033 average. Buyers look set to stay in control over this stretch.
The PROK price prediction for 2035 points to an average of $2.56 (low $1.60, high $4.42) — a potential gain of +47% on today's $1.74. Momentum favours further upside here.
In 2040, PROK is projected to trade between $2.17 and $7.11, averaging $3.83 — a potential gain of +120% from today's $1.74. That is up +50% on the projected 2035 average. Buyers look set to stay in control over this stretch.
ProKidney Corp.'s 2050 outlook centres on $5.14, within a $2.44 to $10.61 range. That is up +34% on the projected 2040 average. That marks a +195% change versus current levels. Momentum favours further upside here.
Investing $1,000 in PROK today (≈ 574.712644 PROK) could be worth
$2,953.64
+$1,953.64 (+195%) by 2050 · US Dollar
Based on the average projected PROK price of $5.14 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PROKwould be worth at today's price.
$1,000 invested in PROK on Jul 10, 2025 (≈ 193.050199 PROK) would be worth
$335.91
-$664.09 (-66.4%) today · 0.34× · US Dollar
Based on a PROK entry price of $5.18 vs. today's $1.74.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.03 | $857.14 | -14.3% |
| 1 month ago | $1.67 | $1,041.92 | +4.2% |
| 3 months ago | $1.95 | $892.31 | -10.8% |
| 6 months ago | $2.33 | $746.78 | -25.3% |
| 1 year ago | $5.18 | $335.91 | -66.4% |
| All time (5.0y) ago | $9.99 | $174.21 | -82.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PROK forecast.
Our base-case forecast reaches $3.50 around 2040.
Implied market cap at $3.50: $718.2M
The multi-year forecast outlines a path of gradual expansion with several pivotal years. In 2026 the min price is $1.55, the avg is $1.84 and the max is $2.43 with a 0% ROI and Neutral sentiment. By 2032 the average price rises to $2.58 with a max of $4.25 and a 40% ROI, and the sentiment remains BULLISH.
The 2033 forecast shows an average of $2.90 with a max of $4.88 and a 57.4% ROI, followed by 2034 with an average of $2.81 (max $4.84, 52.9% ROI) and 2035 with an average of $2.77 (max $4.85, 50.4% ROI). The forecast projects substantial upside later, with 2040 averaging $4.22 (max $7.98, 129.4% ROI) and 2050 averaging $5.62 (max $11.86, 205.2% ROI). Sentiment trends bullish from 2032 onward, with higher ranges and ROIs in the outer years.
Tap a question to reveal the answer.
The 2030 forecast shows min $1.31, avg $1.89, max $2.96 with a 2.8% ROI and Neutral sentiment.
Forecasts indicate Neutral sentiment through 2026–2031, followed by a bullish outlook from 2032 onward. The 2032–2050 forecasts show rising averages and higher max prices, with ROIs ranging from 40% to 205.2% and a max price of $11.86 in 2050.
Yes—according to the forecasts, the average price by 2050 is $5.62 and the max by 2050 is $11.86, with notable upside in 2040 ($7.98 max) and 2032–2035 around the $2.58–$2.90 average range.
Current price is $1.84 and market cap is $555.79M.
The 30-day picture shows a bullish sentiment with RSI 14 at 50. The stock trades around the SMA50 of $1.80 and the SMA200 of $2.21, with near-term support at $1.64 and resistance at $2.04; the 30-day range spans $1.43 to $2.36.
ProKidney Corp. Community Discussion
0Share your ProKidney Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.